LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression

ErbB2/HER2/Neu-overexpressing breast cancers are characterized by poor survival due to high proliferation and metastasis rates and identifying downstream targets of ErbB2 should facilitate developing novel therapies for this disease. Gene expression profiling revealed the transcriptional regulator L...

Descripción completa

Detalles Bibliográficos
Autores principales: Montañez-Wiscovich, ME, Seachrist, DD, Landis, MD, Visvader, J, Andersen, B, Keri, RA
Formato: Texto
Lenguaje:English
Publicado: 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762490/
https://www.ncbi.nlm.nih.gov/pubmed/19648968
http://dx.doi.org/10.1038/onc.2009.221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762490/
https://www.ncbi.nlm.nih.gov/pubmed/19648968
http://dx.doi.org/10.1038/onc.2009.221

Ejemplares similares